Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00974623 · ClinicalTrials.gov registry record
Bone Graft Materials Observational Registry
A clinical trial, sponsored by Baxter Healthcare Corporation.
- Terminated
- Registry status
- 329
- Enrollment target
NCT00974623 is a clinical trial that was terminated before completion, run by Baxter Healthcare Corporation. The registered enrollment target is 329 participants.
The verdict
NCT00974623 was terminated before completion, sponsored by Baxter Healthcare Corporation.
- TERMINATED
- Registry status
- 329 participants
- Enrollment target
Study Summary
A multi-center, prospective, observational patient registry to collect information on the clinical outcomes and "real world" use of approved and commercially available bone graft substitutes, autograft and allograft.
Interventions
- DEVICE Bone graft substitute, autograft or allograft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 329 participants |
| Start Date | 2009-09 |
| Est. Completion | 2013-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00974623
The ClinicalTrials.gov registry entry for NCT00974623 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 329 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baxter Healthcare Corporation, which has 46 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bone graft substitute, autograft or allograft is the first listed.
NCT00974623 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00974623 about?
NCT00974623 is a clinical study titled "Bone Graft Materials Observational Registry". A multi-center, prospective, observational patient registry to collect information on the clinical outcomes and "real world" use of approved and commercially available bone graft substitutes, autograft and allograft.
What is the current status of trial NCT00974623?
This trial is currently terminated. The enrollment target is 329 participants. The study started on 2009-09. Estimated completion is 2013-11.
What interventions are being tested in trial NCT00974623?
The interventions under investigation include: Bone graft substitute, autograft or allograft (DEVICE).
Who is sponsoring clinical trial NCT00974623?
This trial is sponsored by Baxter Healthcare Corporation, which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.